Profit Or Loss [Abstract]

Mithra Pharmaceuticals S.A. - Filing #3183077

Concept 2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
66,997,000 EUR
22,668,000 EUR
Other income
7,196,000 EUR
4,809,000 EUR
Profit (loss) from operating activities
26,245,000 EUR
87,875,000 EUR
Finance income
9,852,000 EUR
2,838,000 EUR
Finance costs
23,422,000 EUR
13,116,000 EUR
Profit (loss) before tax
11,480,000 EUR
123,769,000 EUR
Tax expense (income)
48,139,000 EUR
6,895,000 EUR
Profit (loss)
59,620,000 EUR
59,620,000 EUR
116,875,000 EUR
116,875,000 EUR
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent
59,620,000 EUR
116,875,000 EUR
Profit (loss), attributable to non-controlling interests
- EUR
- EUR
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
1.22
2.69
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
1.22
2.69

Talk to a Data Expert

Have a question? We'll get back to you promptly.